VRT 0.00% $8.10 virtus health limited

Ann: Appendix 4D & Interim Financial Report 31 December 2017, page-2

  1. 63 Posts.
    lightbulb Created with Sketch. 3
    Great result.

    Revenue, NPAT, international Segment EBITDA, dividend all up nicely on PCP.

    Long term growth story starting to unfold.

    Virtus significantly undervalued IMO. This result should boost the SP IMHO.

    GLTAH!
 
watchlist Created with Sketch. Add VRT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.